Effect of Selective Heart Rate Slowing in Heart Failure With Preserved Ejection Fraction (Q36266675)

13 August 2017

Effect of Selective Heart Rate Slowing in Heart Failure With Preserved Ejection Fraction (English)

1 reference

Heart failure with preserved ejection fraction

13 August 2017

0 references

1 reference

1 reference

inferred from title

author

Hugh Christian Watkins

10

1 reference

13 August 2017

Houman Ashrafian

13

0 references

Amelia Rudd

5

object named as

Amelia Rudd

1 reference

13 August 2017

8

Jane M Francis

1 reference

13 August 2017

Nikhil Pal

1

1 reference

13 August 2017

Nadiya Sivaswamy

2

1 reference

13 August 2017

Masliza Mahmod

3

1 reference

13 August 2017

Arash Yavari

4

1 reference

13 August 2017

Satnam Singh

6

1 reference

13 August 2017

Dana K Dawson

7

1 reference

13 August 2017

Jeremy S Dwight

9

1 reference

13 August 2017

Stefan Neubauer

11

1 reference

13 August 2017

Michael Frenneaux

12

1 reference

13 August 2017

language of work or name

English

0 references

publication date

2 September 2015

1 reference

13 August 2017

1 reference

13 August 2017

132

1 reference

13 August 2017

18

1 reference

13 August 2017

1719-1725

1 reference

International geographic variation in event rates in trials of heart failure with preserved and reduced ejection fraction

13 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4640051

Cardiac structure and function and prognosis in heart failure with preserved ejection fraction: findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) Trial

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4640051

New strategies for heart failure with preserved ejection fraction: the importance of targeted therapies for heart failure phenotypes

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4640051

The pathophysiology of heart failure with preserved ejection fraction.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4640051

Spironolactone for heart failure with preserved ejection fraction

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4640051

Effect of If-channel inhibition on hemodynamic status and exercise tolerance in heart failure with preserved ejection fraction: a randomized trial.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4640051

Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4640051

Cardiac output response to exercise in relation to metabolic demand in heart failure with preserved ejection fraction

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4640051

Prevalence, clinical phenotype, and outcomes associated with normal B-type natriuretic peptide levels in heart failure with preserved ejection fraction

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4640051

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4640051

Determinants of exercise intolerance in elderly heart failure patients with preserved ejection fraction

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4640051

Diastolic relaxation and compliance reserve during dynamic exercise in heart failure with preserved ejection fraction

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4640051

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4640051

Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4640051

Mode of death in patients with heart failure and a preserved ejection fraction: results from the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) trial

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4640051

The role of the funny current in pacemaker activity.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4640051

2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4640051

Disease-specific health-related quality of life questionnaires for heart failure: a systematic review with meta-analyses

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4640051

Irbesartan in patients with heart failure and preserved ejection fraction

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4640051

Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4640051

Outcome of heart failure with preserved ejection fraction in a population-based study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4640051

Trends in prevalence and outcome of heart failure with preserved ejection fraction

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4640051

ATS/ACCP Statement on cardiopulmonary exercise testing

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4640051

Mechanisms of exercise intolerance in heart failure with preserved ejection fraction: the role of abnormal peripheral oxygen extraction.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4640051

Ivabradine in stable coronary artery disease without clinical heart failure.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4640051

Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4640051

Heart failure with preserved ejection fraction is characterized by dynamic impairment of active relaxation and contraction of the left ventricle on exercise and associated with myocardial energy deficiency.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4640051

Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4640051

Ventilatory and heart rate responses to exercise : better predictors of heart failure mortality than peak oxygen consumption

22 September 2018

1 reference

12 December 2020

Diastolic heart failure--abnormalities in active relaxation and passive stiffness of the left ventricle

1 reference

12 December 2020

Regulation of stroke volume during submaximal and maximal upright exercise in normal man

1 reference

12 December 2020

Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure

1 reference

12 December 2020

Mechanism of augmented rate of left ventricular filling during exercise

1 reference

12 December 2020

Oxygen uptake efficiency slope: a new index of cardiorespiratory functional reserve derived from the relation between oxygen uptake and minute ventilation during incremental exercise

1 reference

12 December 2020

Chronotropic incompetence and its contribution to exercise intolerance in older heart failure patients

1 reference

12 December 2020

Impaired chronotropic and vasodilator reserves limit exercise capacity in patients with heart failure and a preserved ejection fraction

1 reference

12 December 2020

Control of in vivo left ventricular [correction] contraction/relaxation kinetics by myosin binding protein C: protein kinase A phosphorylation dependent and independent regulation

1 reference

12 December 2020

Prognosis of heart failure with preserved ejection fraction: a 5 year prospective population-based study

1 reference

12 December 2020

Impaired heart rate recovery and chronotropic incompetence in patients with heart failure with preserved ejection fraction

1 reference

12 December 2020

Aldosterone inhibition in patients with heart failure with preserved ejection fraction--reply

1 reference

12 December 2020

10.1161/CIRCULATIONAHA.115.017119

Identifiers

DOI

1 reference

13 August 2017

1 reference

13 August 2017

1 reference